Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2017, Article ID 1848375, 13 pages
https://doi.org/10.1155/2017/1848375
Review Article

Review of and Updates on Hypertension in Obstructive Sleep Apnea

1Department of Medicine, West Virginia University School of Medicine, Morgantown, WV, USA
2Department of Medicine, Division of Nephrology, West Virginia University School of Medicine, Morgantown, WV, USA

Correspondence should be addressed to Sana Akbar; ude.uvw.csh@rabkas

Received 22 May 2017; Accepted 17 August 2017; Published 24 September 2017

Academic Editor: Markus P. Schlaich

Copyright © 2017 Masood Ahmad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Young, P. E. Peppard, and D. J. Gottlieb, “Epidemiology of obstructive sleep apnea: a population health perspective,” The American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 9, pp. 1217–1239, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. P. W. Wilson, R. B. D'Agostino, L. Sullivan, H. Parise, and W. B. Kannel, “Overweight and obesity as determinants of cardiovascular risk; the Framingham experience,” Archives of Internal Medicine, vol. 162, pp. 1867–1872, 2002. View at Publisher · View at Google Scholar
  3. S. Sonne-Holm, T. I. A. Sorensen, G. Jensen, and P. Schnohr, “Independent effects of weight change and attained body weight on prevalence of arterial hypertension in obese and non-obese men,” British Medical Journal, vol. 299, no. 6702, pp. 767–770, 1989. View at Publisher · View at Google Scholar · View at Scopus
  4. N. A. Shah, H. K. Yaggi, J. Concato, and V. Mohsenin, “Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death,” Sleep and Breathing, vol. 14, no. 2, pp. 131–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. J. Gottlieb, G. Yenokyan, A. B. Newman et al., “Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study,” Circulation, vol. 122, no. 4, pp. 352–360, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. H. K. Yaggi, J. Concato, W. N. Kernan, J. H. Lichtman, L. M. Brass, and V. Mohsenin, “Obstructive sleep apnea as a risk factor for stroke and death,” The New England Journal of Medicine, vol. 353, no. 19, pp. 2034–2041, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S. Gami, D. E. Howard, E. J. Olson, and V. K. Somers, “Day-night pattern of sudden death in obstructive sleep apnea,” The New England Journal of Medicine, vol. 352, no. 12, pp. 1206–1279, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. F. H. Kuniyoshi, A. Garcia-Touchard, A. S. Gami et al., “Day-night variation of acute myocardial infarction in obstructive sleep apnea,” Journal of the American College of Cardiology, vol. 52, no. 5, pp. 343–346, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. P. E. Peppard, T. Young, M. Palta, and J. Skatrud, “Prospective study of the association between sleep-disordered breathing and hypertension,” The New England Journal of Medicine, vol. 342, no. 19, pp. 1378–1384, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Durán-Cantolla, F. Aizpuru, C. Martínez-Null, and F. Barbé-Illa, “Obstructive sleep apnea/hypopnea and systemic hypertension,” Sleep Medicine Reviews, vol. 13, no. 5, pp. 323–331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. Marin, A. Agusti, I. Villar et al., “Association between treated and untreated obstructive sleep apnea and risk of hypertension,” The Journal of the American Medical Association, vol. 307, no. 20, pp. 2169–2176, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Guillot, E. Sforza, E. Achour-Crawford et al., “Association between severe obstructive sleep apnea and incident arterial hypertension in the older people population,” Sleep Medicine, vol. 14, no. 9, pp. 838–842, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. R. C. Hermida, D. E. Ayala, M. H. Smolensky, J. R. Fernández, A. Mojón, and F. Portaluppi, “Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention,” Sleep Medicine Reviews, vol. 33, pp. 17–27, 2017. View at Publisher · View at Google Scholar
  14. W. Zhang and L.-Y. Si, “Obstructive sleep apnea syndrome (OSAS) and hypertension: Pathogenic mechanisms and possible therapeutic approaches,” Upsala Journal of Medical Sciences, vol. 117, no. 4, pp. 370–382, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Durán, S. Esnaola, R. Rubio, and Á. Iztueta, “Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 3, part 1, pp. 685–689, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. P. E. Peppard, T. Young, J. H. Barnet, M. Palta, E. W. Hagen, and K. M. Hla, “Increased prevalence of sleep-disordered breathing in adults,” The American Journal of Epidemiology, vol. 177, no. 9, pp. 1006–1014, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. P. M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P. K. Whelton, and J. He, “Global burden of hypertension: analysis of worldwide data,” The Lancet, vol. 365, no. 9455, pp. 217–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Young, P. Peppard, M. Palta et al., “Population-based study of sleep-disordered breathing as a risk factor for hypertension,” Archives of Internal Medicine, vol. 157, no. 15, pp. 1746–1752, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Javier Nieto, T. B. Young, B. K. Lind et al., “Association of sleep-disordered breathing sleep apnea, and hypertension in a large community-based study,” Journal of the American Medical Association, vol. 283, no. 14, pp. 1829–1836, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Lavie, P. Herer, and V. Hoffstein, “Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study,” British Medical Journal, vol. 320, no. 7233, pp. 479–482, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. E. C. Fletcher, R. D. DeBehnke, M. S. Lovoi, and A. B. Gorin, “Undiagnosed sleep apnea in patients with essential hypertension,” Annals of Internal Medicine, vol. 103, no. 2, pp. 190–195, 1985. View at Publisher · View at Google Scholar · View at Scopus
  22. D. S. Silverberg and A. Oksenberg, “Are sleep-related breathing disorders important contributing factors to the production of essential hypertension?” Current Hypertension Reports, vol. 3, no. 3, pp. 209–215, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. A. J. Williams, D. Houston, S. Finberg, C. Lam, J. L. Kinney, and S. Santiago, “Sleep apnea syndrome and essential hypertension,” The American Journal of Cardiology, vol. 55, no. 8, pp. 1019–1022, 1985. View at Publisher · View at Google Scholar · View at Scopus
  24. A. G. Logan, S. M. Perlikowski, A. Mente et al., “High prevalence of unrecognized sleep apnoea in drug-resistant hypertension,” Journal of Hypertension, vol. 19, no. 12, pp. 2271–2277, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. R. P. Pedrosa, L. F. Drager, C. C. Gonzaga et al., “Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension,” Hypertension, vol. 58, no. 5, pp. 811–817, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Demede, A. Pandey, F. Zizi et al., “Resistant hypertension and obstructive sleep apnea in the primary-care setting,” International Journal of Hypertension, vol. 2011, Article ID 340929, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. R. L. Verrier, J. E. Muller, and J. A. Hobson, “Sleep, dreams, and sudden death: The case for sleep as an autonomic stress test for the heart,” Cardiovascular Research, vol. 31, no. 2, pp. 181–211, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Spiegel, E. Tasali, P. Penev, and E. van Cauter, “Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite,” Annals of Internal Medicine, vol. 141, no. 11, pp. 846–850, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. R. J. Kuczmarski, K. M. Flegal, S. M. Campbell, and C. L. Johnson, “Increasing Prevalence of Overweight Among US Adults: The National Health and Nutrition Examination Surveys, 1960 to 1991,” JAMA: The Journal of the American Medical Association, vol. 272, no. 3, pp. 205–211, 1994. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Hajjar and T. A. Kotchen, “Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000,” Journal of the American Medical Association, vol. 290, no. 2, pp. 199–206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. E. O'Brien, J. Sheridan, and K. O'Malley, “DIPPERS AND NON-DIPPERS,” The Lancet, vol. 332, no. 8607, p. 397, 1988. View at Publisher · View at Google Scholar · View at Scopus
  32. G. T. O'Connor, B. Caffo, A. B. Newman et al., “Prospective study of sleep-disordered breathing and hypertension: The sleep heart health study,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 12, pp. 1159–1164, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. E. O. Bixler, A. N. Vgontzas, H.-M. Lin et al., “Association of hypertension and sleep-disordered breathing,” Archives of Internal Medicine, vol. 160, no. 15, pp. 2289–2295, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. D. C. Haas, G. L. Foster, F. J. Nieto et al., “Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the sleep heart health study,” Circulation, vol. 111, no. 5, pp. 614–621, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. K. M. Hla, T. Young, L. Finn, P. E. Peppard, M. Szklo-Coxe, and M. Stubbs, “Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study,” Sleep, vol. 31, no. 6, pp. 795–800, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. P. E. Peppard, M. Szklo-Coxe, K. M. Hla, and T. Young, “Longitudinal association of sleep-related breathing disorder and depression,” Archives of Internal Medicine, vol. 166, no. 16, pp. 1709–1715, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Arzt, T. Young, L. Finn, J. B. Skatrud, and T. D. Bradley, “Association of sleep-disordered breathing and the occurrence of stroke,” The American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 11, pp. 1447–1451, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Young, L. Finn, P. E. Peppard et al., “Sleep disordered breathing and mortality: eighteen-year follow-up of the wisconsin sleep cohort,” Sleep, vol. 31, no. 8, pp. 1071–1078, 2008. View at Google Scholar · View at Scopus
  39. I. Cano-Pumarega, J. Durán-Cantolla, F. Aizpuru et al., “Obstructive sleep apnea and systemic hypertension - Longitudinal study in the general population: The vitoria sleep cohort,” American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 11, pp. 1299–1304, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. ESH/ESC, “Force for the Management of Arterial Hypertension,” Journal of Hypertension, vol. 31, no. 10, pp. 1925–1938, 2013. View at Google Scholar
  41. E. Ingelsson, K. Björklund-Bodegård, L. Lind, J. Ärnlöv, and J. Sundström, “Diurnal blood pressure pattern and risk of congestive heart failure,” Journal of the American Medical Association, vol. 295, no. 24, pp. 2859–2866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Timio, S. Venanzi, S. Lolli et al., “'Non-dipper' hypertensive patients and progressive renal insufficiency: A 3-year longitudinal study,” Clinical Nephrology, vol. 43, no. 6, pp. 382–387, 1995. View at Google Scholar · View at Scopus
  43. S. Hoshide, K. Kario, Y. Hoshide et al., “Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives,” American Journal of Hypertension, vol. 16, no. 6, pp. 434–438, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Boggia, Y. Li, L. Thijs et al., “Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study,” Lancet, vol. 370, no. 9594, pp. 1219–1229, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. W. Pankow, B. Nabe, A. Lies et al., “Influence of sleep apnea on 24-hour blood pressure,” Chest, vol. 112, no. 5, pp. 1253–1258, 1997. View at Publisher · View at Google Scholar · View at Scopus
  46. J. S. Loredo, S. Ancoli-Israel, and J. E. Dimsdale, “Sleep quality and blood pressure dipping in obstructive sleep apnea,” American Journal of Hypertension, vol. 14, no. 9 I, pp. 887–892, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. H. M. Engleman, K. Gough, S. E. Martin, R. N. Kingshott, P. L. Padfield, and N. J. Douglas, “Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: Effects in 'non-dippers',” Sleep, vol. 19, no. 5, pp. 378–381, 1996. View at Publisher · View at Google Scholar · View at Scopus
  48. E. Sforza, F. Chouchou, P. Collet, V. Pichot, J. C. Barthélémy, and F. Roche, “Sex differences in obstructive sleep apnoea in an elderly French population,” European Respiratory Journal, vol. 37, no. 5, pp. 1137–1143, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. F. Kapsimalis and M. H. Kryger, “Gender and obstructive sleep apnea syndrome, part 2: Mechanisms,” Sleep, vol. 25, no. 5, pp. 499–506, 2002. View at Google Scholar · View at Scopus
  50. D. R. Dancey, P. J. Hanly, C. Soong, B. Lee, J. Shepard, and V. Hoffstein, “Gender Differences in Sleep Apnea,” Chest, vol. 123, no. 5, pp. 1544–1550, 2003. View at Publisher · View at Google Scholar
  51. R. P. Millman, C. C. Carlisle, S. T. McGarvey, S. E. Eveloff, and P. D. Levinson, “Body Fat Distribution and Sleep Apnea Severity in Women,” Chest, vol. 107, no. 2, pp. 362–366, 1995. View at Publisher · View at Google Scholar
  52. G. Pillar, A. Malhotra, R. Fogel, J. Beauregard, R. Schnall, and D. P. White, “Airway mechanics and ventilation in response to resistive loading during sleep: influence of gender,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 5, pp. 1627–1632, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. J. B. Schellenberg, G. Maislin, and R. J. Schwab, “Physical findings and the risk for obstructive sleep apnea: the importance of oropharyngeal structures,” The American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 2, pp. 740–748, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. D. R. Dancey, P. J. Hanly, C. Soong, B. Lee, and V. Hoffstein, “Impact of menopause on the prevalence and severity of sleep apnea,” Chest, vol. 120, no. 1, pp. 151–155, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. P. V. Tishler, E. K. Larkin, M. D. Schluchter, and S. Redline, “Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing,” Journal of the American Medical Association, vol. 289, no. 17, pp. 2230–2237, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. E. O. Bixler, A. N. Vgontzas, H. Lin et al., “Prevalence of sleep-disordered breathing in women: effects of gender,” The American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 3, pp. 608–613, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Young, R. Hutton, L. Finn, S. Badr, and M. Palta, “The gender bias in sleep apnea diagnosis: are women missed because they have different symptoms?” Archives of Internal Medicine, vol. 156, no. 21, pp. 2445–2451, 1996. View at Publisher · View at Google Scholar · View at Scopus
  58. C. O'Connor, K. S. Thornley, and P. J. Hanly, “Gender differences in the polysomnographic features of obstructive sleep apnea,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 5, pp. 1465–1472, 2000. View at Publisher · View at Google Scholar · View at Scopus
  59. V. Mohsenin, “Obstructive sleep apnea and hypertension: a critical review,” Current hypertension reports, vol. 16, no. 10, p. 482, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Hedner, K. Bengtsson-Boström, Y. Peker, L. Grote, L. Råstam, and U. Lindblad, “Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case—control study,” European Respiratory Journal, vol. 27, no. 3, pp. 564–570, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Hedner, H. Ejnell, J. Sellgren, T. Hedner, and G. Wallin, “Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importanee for the development of hypertension?” Journal of Hypertension, Supplement, vol. 6, no. 4, pp. S529–S531, 1988. View at Publisher · View at Google Scholar · View at Scopus
  62. V. K. Somers, M. E. Dyken, and J. L. Skinner, “Autonomic and hemodynamic responses and interactions during the Mueller maneuver in humans,” Journal of the Autonomic Nervous System, vol. 44, no. 2-3, pp. 253–259, 1993. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Okcay, V. K. Somers, and S. M. Caples, “Obstructive sleep apnea and hypertension,” Journal of Clinical Hypertension, vol. 10, no. 7, pp. 549–555, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. R. Tamisier, J. L. Pépin, J. Rémy et al., “14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans,” The European Respiratory Journal, vol. 37, no. 1, pp. 119–128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. V. K. Somers, M. E. Dyken, A. L. Mark, and F. M. Abboud, “Sympathetic-nerve activity during sleep in normal subjects,” The New England Journal of Medicine, vol. 328, no. 5, pp. 303–307, 1993. View at Publisher · View at Google Scholar · View at Scopus
  66. V. K. Somers, A. L. Mark, D. C. Zavala, and F. M. Abboud, “Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans,” Journal of Applied Physiology, vol. 67, no. 5, pp. 2095–2100, 1989. View at Google Scholar · View at Scopus
  67. M. L. Smith, O. N. W. Niedermaier, S. M. Hardy, M. J. Decker, and K. P. Strohl, “Role of hypoxemia in sleep apnea-induced sympathoexcitation,” Journal of the Autonomic Nervous System, vol. 56, no. 3, pp. 184–190, 1996. View at Publisher · View at Google Scholar · View at Scopus
  68. V. K. Somers, M. E. Dyken, M. P. Clary, and F. M. Abboud, “Sympathetic neural mechanisms in obstructive sleep apnea,” Journal of Clinical Investigation, vol. 96, no. 4, pp. 1897–1904, 1995. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Narkiewicz, P. J. H. van de Borne, N. Montano, M. E. Dyken, B. G. Phillips, and V. K. Somers, “Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea,” Circulation, vol. 97, no. 10, pp. 943–945, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Narkiewicz, P. J. H. Van De Borne, R. L. Cooley, M. E. Dyken, and V. K. Somers, “Sympathetic activity in obese subjects with and without obstructive sleep apnea,” Circulation, vol. 98, no. 8, pp. 772–776, 1998. View at Publisher · View at Google Scholar · View at Scopus
  71. K. Narkiewicz, N. Montano, C. Cogliati, P. J. H. van de Borne, M. E. Dyken, and V. K. Somers, “Altered cardiovascular variability in obstructive sleep apnea,” Circulation, vol. 98, no. 11, pp. 1071–1077, 1998. View at Publisher · View at Google Scholar · View at Scopus
  72. J. P. Singh, M. G. Larson, H. Tsuji, J. C. Evans, C. J. O'Donnell, and D. Levy, “Reduced heart rate variability and new-onset hypertension: Insights into pathogenesis of hypertension: The Framingham Heart Study,” Hypertension, vol. 32, no. 2, pp. 293–297, 1998. View at Publisher · View at Google Scholar · View at Scopus
  73. H. Tsuji, M. G. Larson, F. J. Venditti Jr. et al., “Impact of reduced heart rate variability on risk for cardiac events: The Framingham Heart Study,” Circulation, vol. 94, no. 11, pp. 2850–2855, 1996. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Frattola, G. Parati, C. Cuspidi, F. Albini, and G. Mancia, “Prognostic value of 24-hour blood pressure variability,” Journal of Hypertension, vol. 11, no. 10, pp. 1133–1137, 1993. View at Publisher · View at Google Scholar · View at Scopus
  75. X. Copie, K. Hnatkova, A. Staunton, L. Fei, J. A. Camm, and M. Malik, “Predictive Power of Increased Heart Rate Versus Depressed Left Ventricular Ejection Fraction and Heart Rate Variability for Risk Stratification after Myocardial Infarction: Results of a Two-Year Follow-Up Study,” Journal of the American College of Cardiology, vol. 27, no. 2, pp. 270–276, 1996. View at Publisher · View at Google Scholar · View at Scopus
  76. T. D. Bradley and J. S. Floras, “Obstructive sleep apnoea and its cardiovascular consequences,” The Lancet, vol. 373, no. 9657, pp. 82–93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. J. Staessen, C. J. Bulpitt, E. O'Brien et al., “The diurnal blood pressure profile. A population study,” American Journal of Hypertension, vol. 5, no. 6, pp. 386–392, 1992. View at Publisher · View at Google Scholar · View at Scopus
  78. J. A. Staessen, R. H. Fagard, P. J. Lijnen, L. Thijs, R. Van Hoof, and A. K. Amery, “Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies,” The American Journal of Cardiology, vol. 67, no. 8, pp. 723–727, 1991. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Kato, P. Roberts-Thomson, B. G. Phillips et al., “Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea,” Circulation, vol. 102, no. 21, pp. 2607–2610, 2000. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Atkeson, S. Y. Yeh, A. Malhotra, and S. Jelic, “Endothelial Function in Obstructive Sleep Apnea,” Progress in Cardiovascular Diseases, vol. 51, no. 5, pp. 351–362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. L. Lavie, “Oxidative stress-a unifying paradigm in obstructive sleep apnea and comorbidities,” Progress in Cardiovascular Diseases, vol. 51, no. 4, pp. 303–312, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. W. T. McNicholas, “Obstructive sleep apnea and inflammation,” Progress in Cardiovascular Diseases, vol. 51, no. 5, pp. 392–399, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. J. T. Carlson, C. Rångemark, and J. A. Hedner, “Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea,” Journal of Hypertension, vol. 14, no. 5, pp. 577–584, 1996. View at Publisher · View at Google Scholar · View at Scopus
  84. H. Kraiczi, J. Hedner, Y. Peker, and J. Carlson, “Increased vasoconstrictor sensitivity in obstructive sleep apnea,” Journal of Applied Physiology, vol. 89, no. 2, pp. 493–498, 2000. View at Google Scholar · View at Scopus
  85. M. S. M. Ip, B. Lam, L.-Y. Chan et al., “Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 6, pp. 2166–2171, 2000. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Noda, S. Nakata, Y. Koike et al., “Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome,” Hypertension Research, vol. 30, no. 8, pp. 669–676, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Kourembanas, P. A. Marsden, L. P. McQuillan, and D. V. Faller, “Hypoxia induces endothelin gene expression and secretion in cultured human endothelium,” The Journal of Clinical Investigation, vol. 88, no. 3, pp. 1054–1057, 1991. View at Publisher · View at Google Scholar · View at Scopus
  88. B. G. Phillips, K. Narkiewicz, C. A. Pesek, W. G. Haynes, M. E. Dyken, and V. K. Somers, “Effects of obstructive sleep apnea on endothelin-1 and blood pressure,” Journal of Hypertension, vol. 17, no. 1, pp. 61–66, 1999. View at Publisher · View at Google Scholar · View at Scopus
  89. P. H. Gjørup, L. Sadauskiene, J. Wessels, O. Nyvad, B. Strunge, and E. B. Pedersen, “Abnormally Increased Endothelin-1 in Plasma During the Night in Obstructive Sleep Apnea: Relation to Blood Pressure and Severity of Disease,” American Journal of Hypertension, vol. 20, no. 1, pp. 44–52, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. J. Ishikawa, S. Hoshide, K. Eguchi et al., “Increased low-grade inflammation and plasminogen-activator inhibitor-1 level in nondippers with sleep apnea syndrome,” Journal of Hypertension, vol. 26, no. 6, pp. 1181–1187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. A. N. Vgontzas, D. A. Papanicolaou, E. O. Bixler, A. Kales, K. Tyson, and G. P. Chrousos, “Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 5, pp. 1313–1316, 1997. View at Publisher · View at Google Scholar · View at Scopus
  92. H. K. Meier-Ewert, P. M. Ridker, N. Rifai et al., “Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk,” Journal of the American College of Cardiology, vol. 43, no. 4, pp. 678–683, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. E. Ohga, T. Tomita, H. Wada, H. Yamamoto, T. Nagase, and Y. Ouchi, “Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1,” Journal of Applied Physiology, vol. 94, no. 1, pp. 179–184, 2003. View at Publisher · View at Google Scholar · View at Scopus
  94. L. Lavie, “Sleep apnea syndrome, endothelial dysfunction, and cardiovascular morbidity,” Sleep, vol. 27, no. 6, pp. 1053–1055, 2004. View at Google Scholar · View at Scopus
  95. L. Dyugovskaya, P. Lavie, and L. Lavie, “Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients,” The American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 7, pp. 934–939, 2002. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Svatikova, R. Wolk, A. S. Shamsuzzaman, T. Kara, E. J. Olson, and V. K. Somers, “Serum amyloid a in obstructive sleep apnea,” Circulation, vol. 108, no. 12, pp. 1451–1454, 2003. View at Publisher · View at Google Scholar · View at Scopus
  97. K. Minoguchi and M. Adachi, “The role of adrenomedullin in obstructive sleep apnea,” Hypertension Research, vol. 30, no. 11, pp. 1007-1008, 2007. View at Publisher · View at Google Scholar · View at Scopus
  98. N. M. Punjabi and B. A. Beamer, “C-reactive protein is associated with sleep disordered breathing independent of adiposity,” Sleep, vol. 30, no. 1, pp. 29–34, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. V. Mohsenin and F. Urbano, “Circulating antiangiogenic proteins in obstructive sleep apnea and hypertension,” Respiratory Medicine, vol. 105, no. 5, pp. 801–807, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. B. Jafari and V. Mohsenin, “Endothelial dysfunction and hypertension in obstructive sleep apnea - Is it due to intermittent hypoxia?” Journal of Cardiovascular Disease Research, vol. 4, no. 2, pp. 87–91, 2013. View at Publisher · View at Google Scholar · View at Scopus
  101. B. Jafari and V. Mohsenin, “Activation of heme oxygenase and suppression of cGMP are associated with impaired endothelial function in obstructive sleep apnea with hypertension,” American Journal of Hypertension, vol. 25, no. 8, pp. 854–861, 2012. View at Publisher · View at Google Scholar · View at Scopus
  102. J. C. Lam, A. Xu, S. Tam et al., “Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea,” Sleep, vol. 31, no. 12, pp. 1721–1727, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. N. M. Punjabi, J. D. Sorkin, L. I. Katzel, A. P. Goldberg, A. R. Schwartz, and P. L. Smith, “Sleep-disordered breathing and insulin resistance in middle-aged and overweight men,” The American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 5, pp. 677–682, 2002. View at Publisher · View at Google Scholar · View at Scopus
  104. M. S. M. Ip, B. Lam, M. M. T. Ng, W. K. Lam, K. W. T. Tsang, and K. S. L. Lam, “Obstructive sleep apnea is independently associated with insulin resistance,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 5, pp. 670–676, 2002. View at Publisher · View at Google Scholar · View at Scopus
  105. N. M. Punjabi, M. M. Ahmed, V. Y. Polotsky, B. A. Beamer, and C. P. O'Donnell, “Sleep-disordered breathing, glucose intolerance, and insulin resistance,” Respiratory Physiology and Neurobiology, vol. 136, no. 2-3, pp. 167–178, 2003. View at Publisher · View at Google Scholar · View at Scopus
  106. ia. Harsch and sp. schahin, “Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome,” Am J Respir Crit Care Med, vol. 169, no. 2, pp. 156–162, 2004. View at Publisher · View at Google Scholar
  107. I. W. Seetho, R. J. Parker, S. Craig, N. Duffy, K. J. Hardy, and J. P. H. Wilding, “Obstructive sleep apnea is associated with increased arterial stiffness in severe obesity,” Journal of Sleep Research, vol. 23, no. 6, pp. 700–708, 2014. View at Publisher · View at Google Scholar · View at Scopus
  108. M. L. Fung, G. L. Tipoe, and P. S. Leung, “Mechanisms of maladaptive responses of peripheral chemoreceptors to intermittent hypoxia in sleep-disordered breathing,” Sheng li xue bao : [Acta physiologica Sinica], vol. 66, no. 1, pp. 23–29, 2014. View at Google Scholar · View at Scopus
  109. S.-Y. Lam, Y. Liu, K.-M. Ng et al., “Upregulation of a local renin-angiotensin system in the rat carotid body during chronic intermittent hypoxia,” Experimental Physiology, vol. 99, no. 1, pp. 220–231, 2014. View at Publisher · View at Google Scholar · View at Scopus
  110. Z.-N. Jin and Y.-X. Wei, “Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system,” Journal of Geriatric Cardiology, vol. 13, no. 4, pp. 333–343, 2016. View at Publisher · View at Google Scholar · View at Scopus
  111. P. Lloberes, G. Sampol, E. Espinel et al., “A randomized controlled study of CPAP effect on plasma aldosterone concentration in patients with resistant hypertension and obstructive sleep apnea,” Journal of Hypertension, vol. 32, no. 8, pp. 1650–1657, 2014. View at Publisher · View at Google Scholar · View at Scopus
  112. D. D. M. Nicholl, P. J. Hanly, M. J. Poulin et al., “Evaluation of continuous positive airway pressure therapy on renin-angiotensin system activity in obstructive sleep apnea,” American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 5, pp. 572–580, 2014. View at Publisher · View at Google Scholar · View at Scopus
  113. P. Lloberes, G. Sampol, and E. Espinel, “Effect of 3-month CPAP treatment on blood pressure and serum aldosterone concentration in patients with resistant hypertension. Respir,” in Effect of 3-month CPAP treatment on blood pressure and serum aldosterone concentration in patients with resistant hypertension. Eur Respir J, pp. 57–307, Suppl. 57, 307, 2013. View at Google Scholar
  114. X.-L. Zhang and Y.-Q. Li, “Efficacy of continuous positive airway pressure therapy upon resistant hypertension in patients with obstructive sleep apnea hypopnea syndrome,” Zhonghua yi xue za zhi, vol. 89, no. 26, pp. 1811–1814, 2009. View at Google Scholar · View at Scopus
  115. J. J. Sim, E. H. Yan, I. L. A. Liu et al., “Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population,” Journal of Hypertension, vol. 29, no. 8, pp. 1553–1559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. E. Pimenta, D. A. Calhoun, and S. Oparil, “Sleep Apnea, Aldosterone, and Resistant Hypertension,” Progress in Cardiovascular Diseases, vol. 51, no. 5, pp. 371–380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. E. Avrahami and M. Englender, “Relation between CT axial cross-sectional area of the oropharynx and obstructive sleep apnea syndrome in adults,” American Journal of Neuroradiology, vol. 16, no. 1, pp. 135–140, 1995. View at Google Scholar · View at Scopus
  118. A. Yucel, M. Unlu, A. Haktanir, M. Acar, and F. Fidan, “Evaluation of the upper airway cross-sectional area changes in different degrees of severity of obstructive sleep apnea syndrome: Cephalometric and dynamic CT study,” American Journal of Neuroradiology, vol. 26, no. 10, pp. 2624–2629, 2005. View at Google Scholar · View at Scopus
  119. C. B. Bucca, L. Brussino, A. Battisti et al., “Diuretics in obstructive sleep apnea with diastolic heart failure,” Chest, vol. 132, no. 2, pp. 440–446, 2007. View at Publisher · View at Google Scholar · View at Scopus
  120. S. Shiota, C. M. Ryan, K.-L. Chiu et al., “Alterations in upper airway cross-sectional area in response to lower body positive pressure in healthy subjects,” Thorax, vol. 62, no. 10, pp. 868–872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. C. C. Gonzaga, K. K. Gaddam, and M. I. Ahmed, “Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. Clin Sleep Med,” in Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med, pp. 363–368, 4, 363–368, 2010. View at Google Scholar
  122. G. Parati, J. E. Ochoa, G. Bilo et al., “Obstructive sleep apnea syndrome as a cause of resistant hypertension,” Hypertension Research, vol. 37, no. 7, pp. 601–613, 2014. View at Publisher · View at Google Scholar · View at Scopus
  123. D. A. Calhoun, “Obstructive sleep apnea and hypertension,” Current Hypertension Reports, vol. 12, no. 3, pp. 189–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. T. Dudenbostel and D. A. Calhoun, “Resistant hypertension, obstructive sleep apnoea and aldosterone,” Journal of Human Hypertension, vol. 26, no. 5, pp. 281–287, 2012. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Jhamb and M. Unruh, “Bidirectional relationship of hypertension with obstructive sleep apnea,” Current Opinion in Pulmonary Medicine, vol. 20, no. 6, pp. 558–564, 2014. View at Publisher · View at Google Scholar · View at Scopus
  126. O. Friedman, T. D. Bradley, C. T. Chan, R. Parkes, and A. G. Logan, “Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension,” Hypertension, vol. 56, no. 6, pp. 1077–1082, 2010. View at Publisher · View at Google Scholar · View at Scopus
  127. R. Wolk and V. K. Somers, “Obesity-related cardiovascular disease: implications of obstructive sleep apnea,” Diabetes, Obesity and Metabolism, vol. 8, no. 3, pp. 250–260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  128. K. Gaddam, E. Pimenta, S. J. Thomas et al., “Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: A preliminary report,” Journal of Human Hypertension, vol. 24, no. 8, pp. 532–537, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. L. Grote, T. Ploch, J. Heitmann, L. Knaack, T. Penzel, and J. H. Peter, “Sleep-related breathing disorder is an independent risk factor for systemic hypertension,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 6, pp. 1875–1882, 1999. View at Publisher · View at Google Scholar · View at Scopus
  130. A. R. SCHWARTZ, J. A. ROWLEY, C. O'DONNELL, E. D. KING, A. MAYOR, and P. L. SMITH, “Effect of hypertension on upper airway function and sleep apnoea,” Journal of Sleep Research, vol. 4, pp. 83–88, 1995. View at Publisher · View at Google Scholar · View at Scopus
  131. D. W. Carley, S. M. Trbovic, and M. Radulovacki, “Hydralazine reduces elevated sleep apnea index in spontaneously hypertensive (SHR) rats to equivalence with normotensive Wistar-Kyoto rats,” Sleep, vol. 19, no. 5, pp. 363–366, 1996. View at Publisher · View at Google Scholar · View at Scopus
  132. D. W. Carley, S. Trbovic, and M. Radulovacki, “Effect of REM sleep deprivation on sleep apneas in rats,” Experimental Neurology, vol. 137, no. 2, pp. 291–293, 1996. View at Publisher · View at Google Scholar · View at Scopus
  133. E. Garpestad, R. C. Basner, J. Ringler et al., “Phenylephrine-induced hypertension acutely decreases genioglossus EMG activity in awake humans,” Journal of Applied Physiology, vol. 72, no. 1, pp. 110–115, 1992. View at Publisher · View at Google Scholar · View at Scopus
  134. L. Grote, K. Wutkewicz, L. Knaack, T. Ploch, J. Hedner, and J. H. Peter, “Association between blood pressure reduction with antihypertensive treatment and sleep apnea activity,” American Journal of Hypertension, vol. 13, no. 12, pp. 1280–1287, 2000. View at Publisher · View at Google Scholar · View at Scopus
  135. N. J. Ali, R. J. O. Davies, J. A. Fleetham, and J. R. Stradling, “The acute effects of continuous positive airway pressure and oxygen administration on blood pressure during obstructive sleep apnea,” Chest, vol. 101, no. 6, pp. 1526–1532, 1992. View at Publisher · View at Google Scholar · View at Scopus
  136. J. E. Dimsdale, J. S. Loredo, and J. Profant, “Effect of continuous positive airway pressure on blood pressure: A placebo trial,” Hypertension, vol. 35, no. 1 I, pp. 144–147, 2000. View at Publisher · View at Google Scholar · View at Scopus
  137. O. Shirasaki, S. Yamashita, S.-I. Kawara et al., “A new technique for detecting sleep apnea-related "midnight" surge of blood pressure,” Hypertension Research, vol. 29, no. 9, pp. 695–702, 2006. View at Publisher · View at Google Scholar · View at Scopus
  138. K. Kario, “Obstructive sleep apnea syndrome and hypertension: Ambulatory blood pressure,” Hypertension Research, vol. 32, no. 6, pp. 428–432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  139. T. L. Giles, T. J. Lasserson, B. J. Smith, J. White, J. Wright, and C. J. Cates, “Continuous positive airways pressure for obstructive sleep apnoea in adults,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD001106, 2006. View at Google Scholar · View at Scopus
  140. P. Haentjens, A. van Meerhaeghe, A. Moscariello et al., “The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials,” Archives of Internal Medicine, vol. 167, no. 8, pp. 757–764, 2007. View at Publisher · View at Google Scholar · View at Scopus
  141. L. A. Bazzano, Z. Khan, K. Reynolds, and J. He, “Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea,” Hypertension, vol. 50, no. 2, pp. 417–423, 2007. View at Publisher · View at Google Scholar · View at Scopus
  142. F. Barbé, J. Durán-Cantolla, F. Capote et al., “Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 7, pp. 718–726, 2010. View at Publisher · View at Google Scholar · View at Scopus
  143. M. Alajmi, A. T. Mulgrew, J. Fox et al., “Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials,” Lung, vol. 185, no. 2, pp. 67–72, 2007. View at Publisher · View at Google Scholar · View at Scopus
  144. L. Mo and Q. He, “Effect of long-term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome: A meta-analysis of clinical trials,” National Medical Journal of China, vol. 87, no. 17, pp. 1177–1180, 2007. View at Google Scholar · View at Scopus
  145. S. B. Montesi, B. A. Edwards, A. Malhotra, and J. P. Bakker, “Effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials,” Journal of Clinical Sleep Medicine, vol. 8, no. 5, pp. 587–596, 2012. View at Publisher · View at Google Scholar · View at Scopus
  146. C. Fava, S. Dorigoni, F. Dalle Vedove et al., “Effect of CPAP on blood pressure in patients with OSA/hypopnea: A systematic review and meta-analysis,” Chest, vol. 145, no. 4, pp. 762–771, 2014. View at Publisher · View at Google Scholar · View at Scopus
  147. J. P. Bakker, B. A. Edwards, S. P. Gautam et al., “Blood Pressure Improvement with Continuous Positive Airway Pressure is Independent of Obstructive Sleep Apnea Severity,” Journal of Clinical Sleep Medicine. View at Publisher · View at Google Scholar
  148. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report,” The Journal of the American Medical Association, vol. 289, no. 19, pp. 2560–2572, 2003. View at Publisher · View at Google Scholar · View at Scopus
  149. F. Turnbull, “Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials,” The Lancet, vol. 362, no. 9395, pp. 1527–1535, 2003. View at Publisher · View at Google Scholar · View at Scopus
  150. D. J. Bratton, J. R. Stradling, F. Barbé, and M. Kohler, “Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: A meta-analysis using individual patient data from four randomised controlled trials,” Thorax, vol. 69, no. 12, pp. 1128–1135, 2014. View at Publisher · View at Google Scholar · View at Scopus
  151. M. A. Martínez-García, F. Capote, and F. Campos-Rodríguez, “Spanish Sleep Network . Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial,” JAMA ., , 310, vol. 22, pp. 2407–2415, 2013. View at Google Scholar
  152. H. F. Becker, A. Jerrentrup, T. Ploch et al., “Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea,” Circulation, vol. 107, no. 1, pp. 68–73, 2003. View at Publisher · View at Google Scholar · View at Scopus
  153. B. Mokhlesi, L. A. Finn, E. W. Hagen et al., “Obstructive sleep apnea during REM sleep and hypertension: Results of the Wisconsin sleep cohort,” American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 10, pp. 1158–1167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  154. G. V. Robinson, B. A. Langford, D. M. Smith, and J. R. Stradling, “Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA),” Thorax, vol. 63, no. 10, pp. 855–859, 2008. View at Publisher · View at Google Scholar · View at Scopus
  155. J.-P. Baguet, G. Barone-Rochette, and J.-L. Pépin, “Hypertension and obstructive sleep apnoea syndrome: current perspectives,” Journal of Human Hypertension, vol. 23, no. 7, pp. 431–443, 2009. View at Publisher · View at Google Scholar · View at Scopus
  156. A. G. Logan, R. Tkacova, S. M. Perlikowski et al., “Refractory hypertension and sleep apnoea: Effect of CPAP on blood pressure and baroreflex,” European Respiratory Journal, vol. 21, no. 2, pp. 241–247, 2003. View at Publisher · View at Google Scholar · View at Scopus
  157. M. A. Martínez-García, R. Gomez-Aldaraví, J. Soler-Cataluña, T. G. Martinez, B. Bernácer-Alpera, and P. Roman-Sánchez, “Positive effect of CPAP treatment on the control of difficult-to-treat hypertension,” European Respiratory Journal, vol. 29, no. 5, pp. 951–957, 2007. View at Publisher · View at Google Scholar
  158. M. A. Martínez-García, R. Gómez-Aldaraví, J.-J. Soler-Cataluña, T. G. Martínez, B. Bernácer-Alpera, and P. Román-Sánchez, “Positive effect of CPAP treatment on the control of difficult-to-treat hypertension,” European Respiratory Journal, vol. 29, no. 5, pp. 951–957, 2007. View at Publisher · View at Google Scholar · View at Scopus
  159. L. Lozano, J. L. Tovar, G. Sampol et al., “Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial,” Journal of Hypertension, vol. 28, no. 10, pp. 2161–2168, 2010. View at Publisher · View at Google Scholar · View at Scopus
  160. A. Y. Litvin, Z. N. Sukmarova, E. M. Elfimova et al., “Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension.,” Vascular health and risk management, vol. 9, pp. 229–235, 2013. View at Google Scholar · View at Scopus
  161. R. P. Pedrosa, L. F. Drager, L. K. G. de Paula, A. C. S. Amaro, L. A. Bortolotto, and G. Lorenzi-Filho, “Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial,” Chest, vol. 144, no. 5, pp. 1487–1494, 2013. View at Publisher · View at Google Scholar · View at Scopus
  162. I. H. Iftikhar, C. W. Valentine, L. R. A. Bittencourt et al., “Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: A meta-analysis,” Journal of Hypertension, vol. 32, no. 12, pp. 2341–2350, 2014. View at Publisher · View at Google Scholar · View at Scopus
  163. I. Z. Ben-Dov, J. D. Kark, D. Ben-Ishay, J. Mekler, L. Ben-Arie, and M. Bursztyn, “Predictors of all-cause mortality in clinical ambulatory monitoring: Unique aspects of blood pressure during sleep,” Hypertension, vol. 49, no. 6, pp. 1235–1241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  164. P. Verdecchia, C. Porcellati, G. Schillaci et al., “Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension,” Hypertension, vol. 24, no. 6, pp. 793–801, 1994. View at Publisher · View at Google Scholar · View at Scopus
  165. D. Norman, J. S. Loredo, R. A. Nelesen et al., “Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure,” Hypertension, vol. 47, no. 5, pp. 840–845, 2006. View at Publisher · View at Google Scholar · View at Scopus
  166. G. V. Robinson, D. M. Smith, B. A. Langford, R. J. O. Davies, and J. R. Stradling, “Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients,” European Respiratory Journal, vol. 27, no. 6, pp. 1229–1235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  167. F. Barbé, L. R. Mayoralas, J. Duran et al., “Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: a randomized, controlled trial,” Annals of Internal Medicine, vol. 134, no. 11, pp. 1015–1023, 2001. View at Publisher · View at Google Scholar · View at Scopus
  168. D. S. Hui, K. W. To, F. W. Ko et al., “Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness,” Thorax, vol. 61, no. 12, pp. 1083–1090, 2006. View at Publisher · View at Google Scholar · View at Scopus
  169. P. E. Peppard, T. Young, M. Palta, J. Dempsey, and J. Skatrud, “Longitudinal study of moderate weight change and sleep-disordered breathing,” The Journal of the American Medical Association, vol. 284, no. 23, pp. 3015–3021, 2000. View at Publisher · View at Google Scholar · View at Scopus
  170. J. A. Chirinos, I. Gurubhagavatula, K. Teff et al., “CPAP, weight loss, or both for obstructive sleep apnea,” New England Journal of Medicine, vol. 370, no. 24, pp. 2265–2275, 2014. View at Publisher · View at Google Scholar · View at Scopus
  171. I. H. Iftikhar, E. R. Hays, M.-A. Iverson, U. J. Magalang, and A. K. Maas, “Effect of oral appliances on blood pressure in obstructive sleep apnea: A systematic review and meta-analysis,” Journal of Clinical Sleep Medicine, vol. 9, no. 2, pp. 165–174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  172. A. Andren, P. Hedberg, P. Wahlen et al., “Effects of treatment with oral appliance on 24-h blood pressure in patients with obstructive sleep apnea and hypertension: A randomized clinical trial,” Sleep and Breathing, vol. 17, no. 2, pp. 705–712, 2013. View at Publisher · View at Google Scholar · View at Scopus
  173. K. Okuno, B. T. Pliska, M. Hamoda, A. A. Lowe, and F. R. Almeida, “Prediction of oral appliance treatment outcomes in obstructive sleep apnea: A systematic review,” Sleep Medicine Reviews, vol. 30, pp. 25–33, 2016. View at Publisher · View at Google Scholar · View at Scopus
  174. K. Ramar, L. C. Dort, S. G. Katz et al., “Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: An update for 2015,” Journal of Clinical Sleep Medicine, vol. 11, no. 7, pp. 773–828, 2015. View at Publisher · View at Google Scholar · View at Scopus
  175. A. Di Munro, L. Petramala, D. Cotesta et al., “Renin-angiotensin-aldosterone system in patients with sleep apnoea: Prevalence of primary aldosteronism,” JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, vol. 11, no. 3, pp. 165–172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  176. M. G. Ziegler, M. Milic, and H. Elayan, “Cardiovascular regulation in obstructive sleep apnea,” Drug Discovery Today: Disease Models, vol. 8, no. 4, pp. 155–160, 2011. View at Publisher · View at Google Scholar · View at Scopus
  177. J. Heitmann, T. Greulich, C. Reinke et al., “Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with essential hypertension and OSA,” Current Medical Research and Opinion, vol. 26, no. 8, pp. 1925–1932, 2010. View at Publisher · View at Google Scholar · View at Scopus
  178. H. Kraiczi, J. Hedner, Y. Peker, and L. Grote, “Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 5, pp. 1423–1428, 2000. View at Publisher · View at Google Scholar · View at Scopus
  179. P. R. Bartel, M. Loock, P. Becker, E. Robinson, C. Van Der Meyden, and S. Rossouw, “Short-term antihypertensive medication does not exacerbate sleep- disordered breathing in newly diagnosed hypertensive patients,” American Journal of Hypertension, vol. 10, no. 6, pp. 640–645, 1997. View at Publisher · View at Google Scholar · View at Scopus
  180. L. H. Pelttari, E. K. Hietanen, T. T. Salo, M. J. Kataja, and I. M. Kantola, “Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing,” American Journal of Hypertension, vol. 11, no. 3 I, pp. 272–279, 1998. View at Publisher · View at Google Scholar · View at Scopus
  181. F. G. Issa, “Effect of clonidine in obstructive sleep apnea,” American Review of Respiratory Disease, vol. 145, no. 2, pp. 435–439, 1992. View at Publisher · View at Google Scholar · View at Scopus
  182. J. Mayer, U. Weichler, B. Herres-Mayer, H. Schneider, U. Marx, and J. H. Peter, “Influence of metoprolol and cilazapril on blood pressure and on sleep apnea activity,” Journal of Cardiovascular Pharmacology, vol. 16, no. 6, pp. 952–961, 1990. View at Publisher · View at Google Scholar · View at Scopus
  183. J. H. Peter, W. Gassel, J. Mayer et al., “Effects of cilazapril on hypertension, sleep, and apnea,” The American Journal of Medicine, vol. 87, no. 6, 1989. View at Publisher · View at Google Scholar · View at Scopus
  184. U. Weichler, B. Herres-Mayer, J. Mayer, K. Weber, R. Hoffmann, and J. H. Peter, “Influence of antihypertensive drug therapy on sleep pattern and sleep apnea activity,” Cardiology, vol. 78, no. 2, pp. 124–130, 1991. View at Publisher · View at Google Scholar · View at Scopus
  185. A. Cicolin, L. Mangiardi, R. Mutani, and C. Bucca, “Angiotensin-converting enzyme inhibitors and obstructive sleep apnea,” Mayo Clinic Proceedings, vol. 81, no. 1, pp. 53–55, 2006. View at Publisher · View at Google Scholar · View at Scopus
  186. F. B. Nerbass, R. P. Pedrosa, P. R. Genta, L. F. Drager, and G. Lorenzi-Filho, “Calcium channel blockers are independently associated with short sleep duration in hypertensive patients with obstructive sleep apnea,” Journal of Hypertension, vol. 29, no. 6, pp. 1236–1241, 2011. View at Publisher · View at Google Scholar · View at Scopus
  187. H. K. Walia, H. Li, M. Rueschman et al., “Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use,” Journal of Clinical Sleep Medicine, vol. 10, no. 8, pp. 835–843, 2014. View at Publisher · View at Google Scholar · View at Scopus